naltrexone has been researched along with Brain Injuries in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, TS; Lin, CC; Liu, YP; Tung, CS | 1 |
| Lesniak, A; Lipkowski, AW; Misicka, A; Pick, CG; Sacharczuk, M | 1 |
| Dian-san, S; Ke, S; Xiang-rui, W | 1 |
| Armstead, WM; Kulkarni, M | 1 |
| Gong, QZ; Hamm, RJ; Jiang, JY; Lyeth, BG; Young, HF | 1 |
| Faden, AI | 1 |
| Deal, DD; Dewitt, DS; Prough, DS; Uchida, T; Vines, SM | 1 |
| Burke, DT; Calvanio, R; Cheng, J; Dwyer, MA; Gavande, V; Kim, HJ; Leonard, J; Lepak, P | 1 |
| Johnston, P; Keep, RF; Mertz, M; Schultz, CH; Stern, SA; Wang, X; Zink, BJ | 1 |
| Faden, AI; Portoghese, PS; Vink, R | 1 |
| Faden, AI; McIntosh, TK; Rhomhanyi, R; Vink, R | 1 |
11 other study(ies) available for naltrexone and Brain Injuries
| Article | Year |
|---|---|
Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Afferent Pathways; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzylamines; Brain; Brain Injuries; Choice Behavior; Impulsive Behavior; Male; Microdialysis; Naltrexone; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Rats; Rats, Sprague-Dawley; Reaction Time; Zimeldine | 2015 |
Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI).
Topics: Analgesics; Analysis of Variance; Animals; Anxiety; Brain Injuries; Cognition Disorders; Disease Models, Animal; Enkephalins; Exploratory Behavior; Male; Maze Learning; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Recognition, Psychology; Silver Staining | 2016 |
Delta opioid agonist [D-Ala2, D-Leu5] enkephalin (DADLE) reduced oxygen-glucose deprivation caused neuronal injury through the MAPK pathway.
Topics: Animals; Brain Injuries; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Enkephalin, Leucine-2-Alanine; Extracellular Signal-Regulated MAP Kinases; Glucose; JNK Mitogen-Activated Protein Kinases; L-Lactate Dehydrogenase; MAP Kinase Signaling System; Naltrexone; Narcotic Antagonists; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 2009 |
Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury.
Topics: Animals; Animals, Newborn; Brain Injuries; Cyclooxygenase 2; Dynorphins; Enzyme Activation; Female; Glutamic Acid; Indomethacin; Isoenzymes; Male; N-Methylaspartate; Naltrexone; Nitrobenzenes; Nociceptin; Opioid Peptides; Pia Mater; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Superoxides; Swine; Vasodilation | 2002 |
Effects of mu opioid agonist and antagonist on neurological outcome following traumatic brain injury in the rat.
Topics: Animals; Brain Injuries; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Naltrexone; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Treatment Outcome | 1995 |
Comparison of single and combination drug treatment strategies in experimental brain trauma.
Topics: Animals; Azetidines; Behavior, Animal; Brain Injuries; Dextrorphan; Dipeptides; Drug Therapy, Combination; Forelimb; Magnesium Sulfate; Male; Movement; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 1993 |
Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage.
Topics: Animals; Antioxidants; Blood Gas Analysis; Blood Pressure; Brain Injuries; Cats; Cerebral Hemorrhage; Cerebrovascular Circulation; Dopamine; Electroencephalography; Female; Hemoglobins; Male; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Oxygen Consumption; Pregnatrienes; Thyrotropin-Releasing Hormone | 1997 |
Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury.
Topics: Activities of Daily Living; Adolescent; Brain Injuries; Humans; Male; Motor Skills; Naltrexone; Narcotic Antagonists; Prognosis; Speech; Treatment Outcome; Unconsciousness | 2000 |
Effects of ethanol and naltrexone in a model of traumatic brain injury with hemorrhagic shock.
Topics: Animals; Blood Pressure; Brain; Brain Injuries; Cardiac Output; Ethanol; Hydrogen-Ion Concentration; Hypercapnia; Intracranial Pressure; Lactic Acid; Naltrexone; Narcotic Antagonists; Oxygen Consumption; Respiration; Shock, Hemorrhagic; Swine; Veins | 2001 |
kappa-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury.
Topics: Animals; Blood Pressure; Brain Injuries; Magnesium; Magnetic Resonance Spectroscopy; Male; Naltrexone; Narcotic Antagonists; Phosphates; Phosphocreatine; Phosphorylation; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa | 1991 |
Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Brain Injuries; Disease Models, Animal; Energy Metabolism; Magnesium; Magnetic Resonance Spectroscopy; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Phosphates; Phosphocreatine; Phosphorus; Rats; Rats, Inbred Strains | 1990 |